Management of neuropathic cancer pain following WHO analgesic ladder: A prospective study

American Journal of Hospice and Palliative Medicine

Volumn 25, Issue 6, 2009, Pages 447-451

  Mishra, Seema ^a,b   Bhatnagar, Sushma ^a   Gupta, Deepak ^a   Nirwani Goyal, Gaurav ^a   Jain, Roopesh ^a   Chauhan, Himanshu ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b AIIMS Residential Campus (West)   (India)

Author keywords

Adjuvants; Cancer pain; Neuropathic pain; Opioids; WHO analgesic ladder

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE; AMITRIPTYLINE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DEXAMETHASONE; GABAPENTIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CANCER CENTER; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; INDIA; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; NEURALGIA; ORGANIZATION AND MANAGEMENT; PAIN ASSESSMENT; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; AMINES; AMITRIPTYLINE; ANALGESICS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CANCER CARE FACILITIES; CYCLOHEXANECARBOXYLIC ACIDS; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; GUIDELINE ADHERENCE; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 58149115221     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909108322288     Document Type: Article

References (21)

1. Merskey H., Bugduk M. Classification of chronic pain. Descriptors of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle, WA: ISAP Press ; 1994: 209-213.
2. Hempenstall K., Rice ASC. Current options in neuropathic pain. Drugs. 2002 ; 3: 441-448.
3. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999 ; 159: 1931-1937.
4. Backonja M., Beydoun A., Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998 ; 280: 1831-1836.
5. Rowbotham M., Harden N., Stacey B., et al. Gabapentin for the treatment of post herpetic neuralgia: a randomized controlled trial. JAMA. 1998 ; 280: 1837-1842.
6. Dallocchio C., Buffa C., Mazzarello P., et al. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage. 2000 ; 20: 280-285.
7. Rice AS, Maton S. Gabapentin in post herpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001 ; 94: 215-224.
8. Backonja M., Glanzman RL Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003 ; 25: 81-104.
9. Oneschuk D., al- Shahri MZ The pattern of gabapentin use in a tertiary palliative care unit. J Palliat Care. 2003 ; 19: 185-187.
10. Caraceni A., Zecca E., Martini C., et al. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage. 1999 ; 17: 441-445.
11. Detlev FJ Zech, Stefan Grond, John Lynch, Dagmar Hertel, Klaus A Lehmann. Validation of World Health Organization Guidelines for cancer pain relief: a 10 year prospective study. Pain. 1995 ; 63: 65-76.
12. Hanks GW, Justins DM Cancer pain management. Lancet. 1992 ; 339: 1031-1036.
13. Vielhaber A., Portenoy RK Advances in cancer pain management. Hematol Oncol Clin North Am. 2002 ; 16: 527-541.
14. Stefan Grond, Lukas Radbruch, Thomas Meuser, Rainer Sabatowski, Georg Loick, Klaus A Lehmann. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999 ; 79: 15-20.
15. Ashbury AK, Fields HL Pain due to peripheral nerve damage: a hypothesis. Neurology. 1984 ; 34: 1587-1590.
16. Eisenberg E., McNicol ED, Carr DB Efficacy and safety of opioids agonists in the treatment of neuropathic pain of non-malignant origin. JAMA. 2005 ; 293: 3043-3052.
17. Cherry NI, Thaler HT, Friedlander-Klar H., et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled single-dose studies. Neurology. 1994 ; 44: 857-861.
18. Dellemijin PL, Vanneste JA Randomised double-blind active-placebo- controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 1997 ; 349: 753-758.
19. Dellemijn P. Are opioids effective in relieving neuropathic pain ? Pain. 1999 ; 80: 453-462.
20. Twycross RG Pain Relief in Advanced Cancer. Edinburg: Churchill Livingstone ; 1994.
21. World health Organization. Cancer pain relief with guide to opioids availability. 2 nd ed. Geneva: WHO ; 1996.